Meet the Partners - Sphere Fluidics
3DSecret aims to unravel stochastic patterns that drive cancer metastasis. To tackle this challenge, the consortium unites partners from Portugal, Spain, Italy, and the UK. In the coming weeks we will present each of the 3DSecret partners, their dedicated research teams, and how they will contribute to attain the objectives of 3DSecret. Stay tuned!
In a groundbreaking development, Sphere Fluidics (SF), a pioneering Life Sciences SME, has emerged as a frontrunner in the realm of single-cell analysis platforms and tools. Founded as a spin-out from Cambridge University in 2010, SF has rapidly evolved into a formidable force in the industry, driving innovation and transforming scientific research.
Sphere Fluidics (SF)'s relentless pursuit of excellence has led to the successful commercialization of state-of-the-art microfluidic hardware, consumables such as biochips, reagents, and chemicals, as well as sophisticated software tailored for the pharmaceutical sector, biotech companies, and academic institutions. Leveraging its deep-rooted expertise, the company has established modern laboratories situated in Granta Park, Cambridge, UK, serving as hubs for pioneering technology development.
Backed by an exceptional team of scientists and engineers dedicated to research and development, SF has consistently pushed the boundaries of possibility in single-cell analysis. With a robust commercial arm, the company has forged strategic partnerships with 13 international distributors, facilitating the global dissemination of its innovative products.
To fuel its ambitious endeavors, Sphere Fluidics (SF) has successfully raised approximately €50 million in equity and loans, underscoring investor confidence in its vision and capabilities. With a burgeoning customer base exceeding 350 entities worldwide, SF continues to make significant strides in advancing scientific understanding and driving progress in the Life Sciences domain.
The participation of SF in the #3DSecret project is crucial to providing a unique platform that will overcome the bottlenecks of such a combination of microfluidic operations towards standardisation, which will be key to the potential translation of the technology.